HER2-POSITIVE SOLID TUMOR
Clinical trials for HER2-POSITIVE SOLID TUMOR explained in plain language.
Never miss a new study
Get alerted when new HER2-POSITIVE SOLID TUMOR trials appear
Sign up with your email to follow new studies for HER2-POSITIVE SOLID TUMOR, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New drug takes on hard-to-treat HER2 cancers in first human test
Disease control Recruiting nowThis study is the first time a new drug called YH32367 is being tested in people. It aims to see if the drug is safe and can shrink tumors in patients with advanced HER2-positive solid cancers that have spread. About 147 adults with these cancers will take part. The study is not …
Matched conditions: HER2-POSITIVE SOLID TUMOR
Phase: PHASE1, PHASE2 • Sponsor: Yuhan Corporation • Aim: Disease control
Last updated May 22, 2026 13:51 UTC
-
New imaging trick could spot HER2 cancers faster
Diagnosis Recruiting nowThis early-phase study tests a new imaging agent called TGW211 for people with HER2-positive solid tumors. The goal is to see if a special "trigger" can help clear the imaging tracer from healthy organs quickly, making tumors easier to see on scans. About 19 adults will take part…
Matched conditions: HER2-POSITIVE SOLID TUMOR
Phase: EARLY_PHASE1 • Sponsor: Radboud University Medical Center • Aim: Diagnosis
Last updated May 19, 2026 11:47 UTC